Overview
HPV Symposium 2026 — "Leading the Fight Against HPV-Related Cancers: From Prevention to Elimination" is the first regional symposium dedicated exclusively to HPV-related cancers. Convened by the Rofaida Women's Health Organization on Saturday, 12 September 2026 (09:00–16:00) at the Crowne Plaza Riyadh RDC Hotel & Convention, Riyadh, it serves as a national platform for clinicians, policymakers, researchers and public health experts to address the growing burden of HPV-related disease and to translate evidence into national action.
HPV causes six types of cancer affecting both women and men, so the scientific programme is deliberately multidisciplinary: gynecologists, oncologists, otolaryngologists, dermatologists, urologists, colorectal surgeons, pathologists, laboratory specialists, public health leaders and patient advocates share the same stage. Sessions cover HPV vaccination coverage in Saudi Arabia, the national cervical cancer screening programme, self-sampling and HPV primary testing, molecular triage and diagnostics, HPV-driven oropharyngeal cancer, and the broader spectrum of anal, penile, vulvar and vaginal malignancies — closing with an advocacy roadmap for elimination.
The symposium is accredited for 8 CME credit hours and includes lunch, refreshments, conference materials and a certificate of attendance.
Full scientific agenda (PDF): https://assets.cdn.filesafe.space/zwQk0bG0OC9uABmqWJiv/media/6a85ab4762d760a82d087719.pdf
Chair's welcome
Symposium Chair Dr. Fatimah S. Alhamlan (Founder & Vice Chair, Rofaida Women's Health Organization; Consultant & Senior Scientist, KFSH&RC) notes that the meeting "reflects Saudi Arabia's commitment to improving population health through HPV prevention, early detection, and multidisciplinary care," bringing local data and the patient voice into the same discussion as the latest scientific updates. Opening remarks are delivered by HRH Princess Moudi bint Khalid bin Abdulaziz, Chair of Rofaida, followed by a keynote from Dr. Abrar Alasmari (Deputyship of Population Health, Ministry of Health) on Saudi Arabia's vision for the prevention and elimination of HPV-related cancers.
Who should attend
- Obstetricians & Gynecologists
- Oncologists and Surgeons
- ENT Specialists and Dentists
- Dermatologists
- Family Medicine and Primary Care Physicians
- Public Health and Policy Leaders
- Researchers and Healthcare Professionals
- Patient Advocacy Organizations
Sessions at a glance
- Session I — Cervical Cancer: Prevention, Screening and Elimination (chairs: Dr. Aljawharah Alosaimi, Mr. Ahmed Kasem)
- Session II — HPV and Head & Neck Cancer (chairs: Dr. Eiad Alsaeed, Prof. Khalid Al-Qahtani)
- Session III — Beyond Cervical Cancer: The Broader Spectrum of HPV-Related Malignancies (chairs: Dr. Khalid Akkor, Dr. Ahmed Alayoubi)
- Session IV — Advocacy, Public Health and Future Directions, including a patient-advocate perspective from cervical cancer survivor Eng. Sara Alotaibi
Registration & contact
Registration is handled through the official ticketing portal; payment is due at registration and confirms your place. Cancellations must be notified in writing at least 30 days before the event (less a USD 100 administration charge); later cancellations are non-refundable.
About Rofaida
Rofaida is a Riyadh-based non-profit established in 2016 to promote women's health and well-being with a focus on sexual and reproductive health, designing user-centred, impact-driven programmes with accessible Arabic content.
